Clinical Trial Update: Treating Nonalcoholic Steatohepatitis (NASH) With Metformin [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating metformin for nonalcoholic steatohepatitis (NASH) was completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis
• Viral Hepatitis

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hepatitis | Phase 2 | Status: COMPLETED | Results posted: 2011-07-20